US Stock MarketDetailed Quotes

YMAB Y-mAbs Therapeutics

Watchlist
  • 10.410
  • +0.310+3.07%
Close Nov 22 16:00 ET
  • 10.410
  • 0.0000.00%
Post 16:02 ET
466.25MMarket Cap-19277P/E (TTM)

Y-mAbs Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-697.09%-10.67M
106.29%298K
73.51%-3.48M
64.13%-27.23M
7.22%-8.04M
93.04%-1.34M
79.51%-4.73M
47.35%-13.12M
25.97%-75.92M
74.42%-8.66M
Net income from continuing operations
9.67%-7M
-46.76%-9.25M
-3.74%-6.63M
77.58%-21.43M
-185.39%-988K
71.86%-7.75M
84.68%-6.3M
77.23%-6.39M
-72.90%-95.57M
103.14%1.16M
Operating gains losses
-391.36%-1.18M
172.96%232K
207.89%492K
-135.20%-1.26M
-635.54%-890K
-79.39%405K
-122.36%-318K
-246.62%-456K
88.56%3.58M
-110.56%-121K
Depreciation and amortization
-27.98%121K
-31.70%153K
-12.64%159K
-12.40%735K
-30.00%161K
-25.66%168K
19.15%224K
-6.67%182K
7.29%839K
-20.96%230K
Change In working capital
-298.57%-6.8M
392.89%5.72M
88.57%-1.35M
-90.28%-19.73M
29.87%-9.44M
24.18%3.43M
-170.09%-1.95M
-379.38%-11.76M
-42.38%-10.37M
-306.15%-13.46M
-Change in receivables
7,400.00%18.3M
-4,137.50%-17.63M
130.24%1.87M
-105.91%-9.92M
-9.15%-3.58M
111.94%244K
-119.66%-416K
-282.82%-6.17M
37.51%-4.82M
-632.14%-3.28M
-Change in inventory
45.02%-1.06M
-101.33%-50K
-50.82%-3.38M
237.56%1.64M
545.22%2.05M
-448.91%-1.93M
411.61%3.76M
-2,851.32%-2.24M
78.41%-1.19M
36.55%-460K
-Change in payables and accrued expense
-2,083.96%-19.92M
1,860.19%24.45M
-25.37%-2.62M
-211.86%-4.65M
65.77%-2.18M
-58.20%1M
-247.92%-1.39M
-236.36%-2.09M
-126.82%-1.49M
-769.30%-6.37M
-Change in other current assets
-200.51%-4.13M
73.18%-1.05M
321.33%2.79M
-136.76%-6.8M
-70.62%-5.73M
122.08%4.1M
-516.08%-3.91M
45.13%-1.26M
-863.30%-2.87M
-8.60%-3.36M
Cash from discontinued investing activities
Operating cash flow
-697.09%-10.67M
106.29%298K
73.51%-3.48M
64.13%-27.23M
7.22%-8.04M
93.04%-1.34M
79.51%-4.73M
47.35%-13.12M
25.97%-75.92M
74.42%-8.66M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
--0
--0
--0
----
Financing cash flow
Cash flow from continuing financing activities
979K
1.76M
588K
19.05%100K
100K
0
0
0
-99.92%84K
0
Proceeds from stock option exercised by employees
--979K
--1.76M
--588K
19.05%100K
--100K
--0
--0
--0
-85.74%84K
--0
Cash from discontinued financing activities
Financing cash flow
--979K
--1.76M
--588K
19.05%100K
--100K
--0
--0
--0
-99.92%84K
--0
Net cash flow
Beginning cash position
-11.49%77.81M
-18.22%75.75M
-25.65%78.64M
-41.75%105.76M
-24.41%86.57M
-34.23%87.91M
-40.90%92.63M
-41.75%105.76M
58.39%181.56M
-46.91%114.53M
Current changes in cash
-623.92%-9.69M
143.43%2.06M
77.99%-2.89M
64.22%-27.13M
8.37%-7.94M
93.03%-1.34M
79.51%-4.73M
47.28%-13.12M
-213.53%-75.84M
74.69%-8.66M
Effect of exchange rate changes
--2K
-92.86%1K
111.11%1K
-80.00%7K
101.94%2K
--0
-65.85%14K
-116.98%-9K
-72.87%35K
-298.08%-103K
End cash Position
-21.31%68.12M
-11.49%77.81M
-18.22%75.75M
-25.65%78.64M
-25.65%78.64M
-24.41%86.57M
-34.23%87.91M
-40.90%92.63M
-41.75%105.76M
-41.75%105.76M
Free cash flow
-697.09%-10.67M
106.29%298K
73.51%-3.48M
64.13%-27.23M
7.22%-8.04M
93.04%-1.34M
79.51%-4.73M
47.35%-13.12M
26.66%-75.92M
74.76%-8.66M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -697.09%-10.67M106.29%298K73.51%-3.48M64.13%-27.23M7.22%-8.04M93.04%-1.34M79.51%-4.73M47.35%-13.12M25.97%-75.92M74.42%-8.66M
Net income from continuing operations 9.67%-7M-46.76%-9.25M-3.74%-6.63M77.58%-21.43M-185.39%-988K71.86%-7.75M84.68%-6.3M77.23%-6.39M-72.90%-95.57M103.14%1.16M
Operating gains losses -391.36%-1.18M172.96%232K207.89%492K-135.20%-1.26M-635.54%-890K-79.39%405K-122.36%-318K-246.62%-456K88.56%3.58M-110.56%-121K
Depreciation and amortization -27.98%121K-31.70%153K-12.64%159K-12.40%735K-30.00%161K-25.66%168K19.15%224K-6.67%182K7.29%839K-20.96%230K
Change In working capital -298.57%-6.8M392.89%5.72M88.57%-1.35M-90.28%-19.73M29.87%-9.44M24.18%3.43M-170.09%-1.95M-379.38%-11.76M-42.38%-10.37M-306.15%-13.46M
-Change in receivables 7,400.00%18.3M-4,137.50%-17.63M130.24%1.87M-105.91%-9.92M-9.15%-3.58M111.94%244K-119.66%-416K-282.82%-6.17M37.51%-4.82M-632.14%-3.28M
-Change in inventory 45.02%-1.06M-101.33%-50K-50.82%-3.38M237.56%1.64M545.22%2.05M-448.91%-1.93M411.61%3.76M-2,851.32%-2.24M78.41%-1.19M36.55%-460K
-Change in payables and accrued expense -2,083.96%-19.92M1,860.19%24.45M-25.37%-2.62M-211.86%-4.65M65.77%-2.18M-58.20%1M-247.92%-1.39M-236.36%-2.09M-126.82%-1.49M-769.30%-6.37M
-Change in other current assets -200.51%-4.13M73.18%-1.05M321.33%2.79M-136.76%-6.8M-70.62%-5.73M122.08%4.1M-516.08%-3.91M45.13%-1.26M-863.30%-2.87M-8.60%-3.36M
Cash from discontinued investing activities
Operating cash flow -697.09%-10.67M106.29%298K73.51%-3.48M64.13%-27.23M7.22%-8.04M93.04%-1.34M79.51%-4.73M47.35%-13.12M25.97%-75.92M74.42%-8.66M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0--0--0--0----
Financing cash flow
Cash flow from continuing financing activities 979K1.76M588K19.05%100K100K000-99.92%84K0
Proceeds from stock option exercised by employees --979K--1.76M--588K19.05%100K--100K--0--0--0-85.74%84K--0
Cash from discontinued financing activities
Financing cash flow --979K--1.76M--588K19.05%100K--100K--0--0--0-99.92%84K--0
Net cash flow
Beginning cash position -11.49%77.81M-18.22%75.75M-25.65%78.64M-41.75%105.76M-24.41%86.57M-34.23%87.91M-40.90%92.63M-41.75%105.76M58.39%181.56M-46.91%114.53M
Current changes in cash -623.92%-9.69M143.43%2.06M77.99%-2.89M64.22%-27.13M8.37%-7.94M93.03%-1.34M79.51%-4.73M47.28%-13.12M-213.53%-75.84M74.69%-8.66M
Effect of exchange rate changes --2K-92.86%1K111.11%1K-80.00%7K101.94%2K--0-65.85%14K-116.98%-9K-72.87%35K-298.08%-103K
End cash Position -21.31%68.12M-11.49%77.81M-18.22%75.75M-25.65%78.64M-25.65%78.64M-24.41%86.57M-34.23%87.91M-40.90%92.63M-41.75%105.76M-41.75%105.76M
Free cash flow -697.09%-10.67M106.29%298K73.51%-3.48M64.13%-27.23M7.22%-8.04M93.04%-1.34M79.51%-4.73M47.35%-13.12M26.66%-75.92M74.76%-8.66M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data